New York, NY, Oct. 10, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (NASDAQ: ATON), a specialized digital asset treasury company focused on developing the TON and Telegram ecosystem, and new pioneer in blockchain-based healthcare financing, today announced that Nasdaq has publicly congratulated the company on its innovative approach to funding cancer research through asset tokenization. The recognition was displayed prominently on the iconic Nasdaq Tower in Times Square, marking a significant milestone in th ...

Landmark Initiative Positions AlphaTON at Forefront of Decentralized Science (DeSci) Movement, Leveraging TON Infrastructure to Accelerate Life-Saving Cancer ResearchDover, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) ("AlphaTON" or the "Company"), alongside its wholly owned oncology subsidiary Tarus Therapeutics, LLC (dba Cyncado Therapeutics) ("Cyncado"), today announced a groundbreaking non-binding letter of intent (LOI) to evaluate tokenization of single-indication economic ...

Company invests in DeSci blockchain innovation and purchases native coin of ResearchHub, a decentralized science platform co-founded by Coinbase CEO, Brian Armstrong SARASOTA, FL, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced its initial purchase of ResearchCoin (RSC) as part of its expanded digital assets treasury strategy designed to capture long-term va ...